CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NEFERTITI FTI project focuses on developing a new treatment for bacterial vaginosis and vulvovaginal candidiasis using a pessary containing glucono-δ-lactone. This innovative approach aims to effectively restore vaginal health without contributing to drug resistance, providing a safer alternative to traditional ant…
Bacterial vaginosis (BV) and vulvovaginal candidiasis (VCC) are common vaginal infections caused by Gardnerella and other anaerobic bacteria. or by Candida fungi.
The infection can occur once - the acute form - or recur repeatedly over the course of a year.
About 68m women in Europe and the US are infected each year.
They cause intense physical discomfort, adversely affects quality of life and have heavy socioeconomic costs.
Many women opt to self-treat with non-prescription over-the-counter ant…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Uppsala
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Berlin
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, London
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Denmark, KOBENHAVN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
